Defining the Role of Particle Therapy for Locally Advanced Lung Cancer 

December 4, 2020. 10.15am to 2pm. All times shown in Eastern Standard Time (EST)

Welcome Introduction:

10.15 – 10:13    
Dr Anita Mahajan (PTCOG-NA President) and Dr Brad Hoppe (PTCOG-NA Secretary)


Session 1: Locally Advanced NSCLC and SCLC

Moderator: Dr Brad Hoppe

10:30 – 10:45    
Dosimetric rationale and early clinical data on proton therapy for locally advanced Non-small cell lung cancer - Dr Joe Chang

10:45 – 11:00    
Overview and lessons learned from Phase II and III Randomized controlled studies of proton therapy versus IMRT for locally advanced Non-small cell lung cancer - Dr Xing Liao

11:00 – 11:15   
Rationale and outcomes for using proton therapy for post-operative stage II and III Non-small cell lung cancer - Dr Ramesh Rengan

11:15 – 11:30    
Role of proton therapy in Small Cell Lung Cancer - Dr Chuck Simone

11:30 – 11:45    
PT and Immunotherapy - Dr Abigail Berman

11:45 – 12:00    
Future outlook of clinical trials in locally advanced lung cancer - Dr Jeff Bradley


Question / Discussion time– 15 minutes


Session 2: Treatment Planning of Stage III NSCLC/SCLC

Moderator: Dr Stella Flampouri

12:15 – 13:45
Different institutional approaches to proton planning locally advanced lung cancer     
MDACC approach - Prof Xiaorong Ronald Zhu
Northwestern approach - Dr Mark Pankuch

PTCOG-NA Copyright © 2019. All Rights Reserved.
Powered by APPTIDE | Terms of Service